Lightlake and King's College partner to devleop a naloxone spray to prevent heroin overdose deaths

Lightlake Therapeutics Inc.

U.K. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

King's College London

U.K. / Academic

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced